The serotonin transporter promoter polymorphism (5-HTTLPR) is associated with type 2 diabetes

Clinica Chimica Acta

Volumn 411, Issue 3-4, 2010, Pages 167-171

  Iordanidou, Maria ^a   Tavridou, Anna ^a   Petridis, Ioannis ^a,b   Arvanitidis, Kostas I ^a   Christakidis, Dimitrios ^b   Vargemezis, Vassilios ^b   Manolopoulos, Vangelis G ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b Academic General Hospital Alexandroupolis   (Greece)

Author keywords

5 HTT gene; 5 HTTLPR polymorphism; Obesity; Serotonin; Type 2 diabetes mellitus

Indexed keywords

GENOMIC DNA; SEROTONIN TRANSPORTER;

AGED; ALLELE; ARTICLE; BODY MASS; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; OBESITY; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 72649107179     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.10.022     Document Type: Article

References (28)

1. Lam D.D., and Heisler L.K. Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes. Expert Rev Mol Med 9 (2007) 1-24
2. Smeraldi E., Serretti A., Artioli P., Lorenzi C., and Catalano M. Serotonin-transporter gene-linked polymorphic region: possible pharmacogenetic implications of rare variants. Psychiatr Gen 16 (2006) 153-158
3. Ni W., and Watts S.W. 5-Hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT). Clin Exp Pharmacol Physiol 33 (2006) 575-583
4. Lesch K.P., Balling U., Gross J., et al. Organization of the human serotonin transporter gene. J Neural Transm 95 (1994) 157-162
5. Heils A., Teufel A., Petri S., Stöber G., Riedezez P., Bengel D., et al. Allelic variation of human serotonin transporter gene expession. J Neurochem 66 (1996) 2621-2624
6. Lesch K.P., Wolozin B.L., Estler H.C., Murphy D.L., and Riederer P. Isolation of a cDNA encoding the human brain serotonin transporter. J Neural Transm 91 (1993) 67-73
7. Mortensen O.V., Thomassen M., Larsen M.B., Whittemore S.R., and Wiborg O. Functional analysis of a novel human serotonin transporter gene promoter in immortalized raphe cells. Brain Res Mol Brain Res 68 (1999) 141-148
8. Salkovic Petrisic M., Augood S.J., and Bicknell J. Monoamine transporter gene expression in the central nervous system in diabetes mellitus. J Neurochem 68 (1997) 2435-2441
9. Yamakawa M., Fukushima A., Sakuma K., Yanagisawa Y., and Kagawa Y. Serotonin transporter polymorphisms affect human blood glucose control. Biochem Biophys Res Commun 334 (2005) 1165-1171
10. Huang X.F., Huang X., Han M., Chen F., Storlien L., and Lawrence A.J. 5-HT2A/2C receptor and 5-HT transporter densities in mice prone or resistant to chronic high-fat diet-induced obesity: a quantitative autoradiography study. Brain Res 1018 (2004) 227-235
11. Kaiser R., Tremblay P.B., Roots I., and Brockmoller J. Validity of PCR with emphasis on variable number of tandem repeat analysis. Clin Biochem 35 (2002) 49-56
12. Yonan A.L., Palmer A.A., and Gilliam T.C. Hardy-Weinberg disequilibtium identified genotyping error of the serotonin transporter (SLC6A4) promoter polymorphism. Psychiatr Gen 16 (2006) 31-34
13. 2C receptor is associated with type 2 diabetes in male and female Caucasians. Pharmacogenetics Genom 18 (2008) 153-159
14. MacCall A.L. The impact of diabetes on the CNS. Diabetes 41 (1992) 557-570
15. Peschke E., Peschke D., Hammer T., and Csernus V. Influence of melatonin and serotonin on glucose-stimulated insulin release from perifused rat pancreatic islets in vitro. J Pineal Res 23 (1997) 156-163
16. Nonogaki K., Strack A.M., Dallman M.F., and Tecott L.H. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat Med 4 (1998) 1152-1156
17. Sugimoto Y., Kimura I., Yamada J., Watanabe Y., Takeuchi N., and Horisaka K. Effects of serotonin on blood glucose and insulin levels of glucose- and streptozotocin-treated mice. Jpn J Pharmacol 54 (1990) 93-96
18. Wonziak K.M., and Linnoila M. Hypergycemic properties of serotonin receptor antagonists. Life Sci 49 (1991) 101-109
19. Adeghate E., Ponery A.S., Pallot D., Parvez S.H., and Singh J. Distribution of serotonin and its effect on insulin and glucagons secretion in normal and diabetic pancreatic tissues in rat. Neuro Endocrinol Lett 20 (1999) 315-322
20. Muldoon M.F., Mackey R.H., Korytkowski M.T., Flory J.D., Pollock B.G., and Manuck S.B. The metabolic syndrome is associated with reduced central serotonergic responsivity in healthy community volunteers. J Clin Endocrinol Metab 91 (2006) 718-721
21. Hajduch E., Rencurel F., Balendran A., Batty I.H., Downes C.P., and Hundal H.S. Serotonin (5-Hydroxytryptamine), a novel regulator of glucose transport in rat skeletal muscle. J Biol Chem 274 (1999) 13563-13568
22. Wade J.M., Juneja P., MacKay A.W., Gzaham J., Havel P.J., Tecott L.H., et al. Synergistic impairment of glucose homeostasis in ob/ob mice lacking functional serotonin 2C receptors. Endocrinology 149 (2008) 955-961
23. Hinney A., Barth N., Ziegler A., von Prittwitz S., Hamann A., Hennighausen K., et al. Serotonin transporter gene-linked polymorphic region: allele distributions in relationship to body weight and in anorexia nervosa. Life Sci 6 (1997) 295-303
24. Sookoian S., Gemma C., Garcia S.I., Gianotti T.F., Dieuzeide G., Roussos A., et al. Short allele of serotonin transporter gene promoter is a risk factor for obesity in adolescents. Obesity 15 (2007) 271-276
25. Sookoian S., Gianotti T.F., Gemma C., Burgueño A., and Pirola C.J. Contribution of functional 5-HTTLPR variant of the SLC6A4 gene to obesity risk in male adults. Obesity 16 (2008) 488-491
26. Lan M.Y., Chang Y.Y., Chen W.H., Kao Y.F., Lin H.S., and Liu J.S. J Endocrinol Invest 32 (2009) 119-122
27. Mergen H., Karaaslan C., and Mergen M. Deniz Ozsoy E, Ozata M. LEPR, ADBR3, IRS-1 and 5-HTT genes polymorphisms do not associate with obesity. Endocr J 54 (2007) 89-94
28. Fuemmeler B.F., Agurs-Collins T.D., Mccleron F.J., Kollins S.H., Kail M.F., Bergen A.W., et al. Obesity 16 (2008) 348-355